NLRP3 and hepatocellular carcinoma: The lack of NLRP3 significantly reduced lung cancer metastasis and improved melanoma survival rate while promoting colorectal cancer metastasis and hepatocellular carcinoma progression (Hamarsheh and Zeiser, 2020).